http://golfstakes.com/forum/messages.aspx?TopicID=20423 GolfStakes.com : Community Forum - Announcements - Discount now ! New medicine powder NSI 189 drugs - Messages en-us http://blogs.law.harvard.edu/tech/rss Jitbit AspNetForum Fri, 27 Sep 2019 13:05:55 GMT Fri, 27 Sep 2019 13:05:55 GMT http://golfstakes.com/forum/messages.aspx?TopicID=20423


NSi-189 is neurogenic and nootropic research agent that was developed from nicotinamide and pyrazine. Randomized controlled trials have shown that it stimulates neurogenesis or neuronal cell production in the brain. In animal studies, it has also been shown to increase the volume of hippocampus by 20% thereby reversing behavioral symptoms of depression. Such studies have shown that it may be an effective treatment for depression. It is also thought to be a promising treatment for other condition including post-traumatic stress disorder (PTSD), Alzheimer's disease and age-related cognitive problems.
Quick Details
CAS No.:
1270138-40-3
Other Names:
NSI-189
MF:
C22H30N4O
EINECS No.:
N/M
Place of Origin:
Zhejiang, China
Type:
Vitamins, Amino Acids and Coenzymes, Central Nervous System Agents
Grade Standard:
Medicine Grade
Usage:
Animal Pharmaceuticals
Brand Name:
Aikafu
Model Number:
AKF-F
Purity:
98% Min
Product Name:
NSI-189
Appearance:
White to off white powder
Specification:
99% HPLC
trade assurance:
fast delivery
Test Method:
HPLC UV
Boiling Point:
456.8°C at 760 mmHg
Solubility:
10 mM in DMSO
COA:
AVAILABLE
Application:
Nootropics API
Shelf Life:
2 years from manufacturing date]]> Fri, 27 Sep 2019 13:05:55 GMT